VAXCYTE
Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Companyโs cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyteโs proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks o... f vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. In addition to its pneumococcal conjugate vaccines in development, VAX-24 and VAX-XP, Vaxcyte is leveraging its proprietary platform to advance other novel vaccines, including a prophylactic vaccine to prevent Group A Strep infections (VAX-A1) and a therapeutic vaccine to treat periodontal disease (VAX-PG).
VAXCYTE
Social Links:
Industry:
Biopharma Biotechnology Delivery Service Health Care
Founded:
2013-12-01
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.vaxcyte.com
Total Employee:
11+
Status:
Active
Contact:
(650) 837-0111
Email Addresses:
[email protected]
Total Funding:
384.54 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare DNS WP Engine Dropbox Business
Similar Organizations
Cache
Cache is advancing personalized medicine and digital data storage by making storage and access to biomolecules widely accessible.
Denteric
Denteric is developing a vaccine based on research conducted at the University of Melbourne.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CARB-X
CARB-X investment in Grant - Vaxcyte
CARB-X
CARB-X investment in Grant - Vaxcyte
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series D - Vaxcyte
Longitude Capital
Longitude Capital investment in Series D - Vaxcyte
CTI Life Sciences Fund
CTI Life Sciences Fund investment in Series D - Vaxcyte
RA Capital Management
RA Capital Management investment in Series D - Vaxcyte
Roche Venture Fund
Roche Venture Fund investment in Series D - Vaxcyte
TPG Growth
TPG Growth investment in Series D - Vaxcyte
Foresite Capital
Foresite Capital investment in Series D - Vaxcyte
Janus Henderson Investors
Janus Henderson Investors investment in Series D - Vaxcyte
Key Employee Changes
Date | New article |
---|---|
2020-01-30 | SutroVax Announces Executive Appointment |
Official Site Inspections
http://www.vaxcyte.com Semrush global rank: 1.66 M Semrush visits lastest month: 14.87 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago